Gilead Sciences to Acquire Israel’s Kite Pharma for $11.9 Billion

The American biopharmaceuticals company Gilead Sciences (Nasdaq: GILD) is to buy Israel’s Kite Pharma (Nasdaq: KITE) in a $11.9 billion ...